Fecal microbiota analysis: An overview of sample collection methods and sequencing strategies

Future Microbiology

Volumn 10, Issue 9, 2015, Pages 1485-1504

  Thomas, Vincent ^a   Clark, James ^a   Doré, Joël ^b  

^a Enterome Bioscience   (France)

^b University of Paris Saclay   (France)

Author keywords

16S; clinical trials; DNA extraction; fecal; gut microbiota; metagenomics; quality control; sequencing; stool

Indexed keywords

RNA 16S; BACTERIAL DNA;

BACTERIAL GENOME; BACTERIAL STRAIN; COPY NUMBER VARIATION; DNA EXTRACTION; FECES MICROFLORA; GENE AMPLIFICATION; GENE SEQUENCE; INTESTINE FLORA; NONHUMAN; OPERON; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SPECIES IDENTIFICATION; DNA SEQUENCE; FECES; GENETICS; HUMAN; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; METAGENOMICS; MICROBIOLOGY; PHYLOGENY; PROCEDURES;

BIOMEDICAL RESEARCH; DNA, BACTERIAL; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; METAGENOMICS; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPECIMEN HANDLING;

EID: 84942762191     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.87     Document Type: Review

References (113)

1. Le Chatelier E, Nielsen T, Qin J et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464), 541-546 (2013).
2. Bocci V. The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect. Biol. Med. 35(2), 251-260 (1992).
3. Salazar N, Arboleya S, Valdes L et al. The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front. Genet. 5, 406 (2014).
4. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4554-4561 (2011).
5. Macfarlane S. Antibiotic treatments and microbes in the gut. Environ. Microbiol. 16(4), 919-924 (2014).
6. Seto CT, Jeraldo P, Orenstein R, Chia N, Dibaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for susceptibility. Microbiome 2(2014).
7. Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80(19), 5935-5943 (2014).
8. Clarke SF, Murphy EF, O'Sullivan O et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63(12), 1913-1920 (2014).
9. Biedermann L, Zeitz J, Mwinyi J et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS ONE 8(3), e59260 (2013).
10. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484), 559-563 (2014).
11. Flores R, Shi J, Fuhrman B et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J. Transl. Med. 10, 253 (2012).
12. Flores GE, Caporaso JG, Henley JB et al. Temporal variability is a personalized feature of the human microbiome. Genome Biol. 15(12), 531 (2014).
13. Rajca S, Grondin V, Louis E et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm. Bowel Dis. 20(6), 978-986 (2014).
14. Dicksved J, Halfvarson J, Rosenquist M et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2(7), 716-727 (2008).
15. Kovatcheva-Datchary P, Tremaroli V, Bäckhed F. The gut microbiota. In: The Prokaryotes. Springer, 3-24 (2013).
16. Marteau P, Pochart P, Dore J, Bera-Maillet C, Bernalier A, Corthier G. Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl. Environ. Microbiol. 67(10), 4939-4942 (2001).
17. Van Den Bogert B, De Vos WM, Zoetendal EG, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl. Environ. Microbiol. 77(6), 2071-2080 (2011).
18. Couch RD, Navarro K, Sikaroodi M et al. The approach to sample acquisition and its impact on the derived human fecal microbiome and VOC metabolome. PLoS ONE 8(11), e81163 (2013).
19. Lepage P, Seksik P, Sutren M et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with ibd. Inflamm. Bowel Dis. 11(5), 473-480 (2005).
20. Zoetendal EG, Raes J, Van Den Bogert B et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 6(7), 1415-1426 (2012).
21. Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol. Rev. 37(5), 736-761 (2013).
22. Zoetendal EG, Von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans ADL, De Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68(7), 3401-3407 (2002).
23. Pedron T, Mulet C, Dauga C et al. A crypt-specific core microbiota resides in the mouse colon. MBio 3(3), e00116-12 (2012).
24. Nava GM, Carbonero F, Croix JA, Greenberg E, Gaskins HR. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J. 6(1), 57-70 (2012).
25. Wu GD, Lewis JD, Hoffmann C et al. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16s sequence tags. BMC Microbiol. 10, 206 (2010).
26. Swidsinski A, Loening-Baucke V, Kirsch S, Doerffel Y. [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii]. Gastroenterol. Clin. Biol. 34(Suppl. 1), S79-S92 (2010).
27. Walker AW, Duncan SH, Harmsen HJ, Holtrop G, Welling GW, Flint HJ. The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities. Environ. Microbiol. 10(12), 3275-3283 (2008).
28. Santiago A, Panda S, Mengels G et al. Processing faecal samples: a step forward for standards in microbial community analysis. BMC Microbiol. 14(1), 112 (2014).
29. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 32(9), 920-924 (1997).
30. Fouhy F, Deane J, Rea MC et al. The effects of freezing on faecal microbiota as determined using miseq sequencing and culture-based investigations. PLoS ONE 10(3), e0119355 (2015).
31. Bahl MI, Bergstrom A, Licht TR. Freezing fecal samples prior to DNA extraction affects the firmicutes to bacteroidetes ratio determined by downstream quantitative PCR analysis. FEMS Microbiol. Lett. 329(2), 193-197 (2012).
32. Cardona S, Eck A, Cassellas M et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol. 12(1)(2012).
33. Carroll IM, Ringel-Kulka T, Siddle JP, Klaenhammer TR, Ringel Y. Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS ONE 7(10), e46953 (2012).
34. Lauber CL, Zhou N, Gordon JI, Knight R, Fierer N. Effect of storage conditions on the assessment of bacterial community structure in soil and human-associated samples. FEMS Microbiol. Lett. 307(1), 80-86 (2010).
35. Franzosa EA, Morgan XC, Segata N et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl Acad. Sci. USA 111(22), E2329-E2338 (2014).
36. Ellis HJ, Venturini DS. Demonstration of a frozen sample aliquotter to prepare plasma and serum aliquots without thawing frozen parent samples. Biopreserv. Biobank. 11(3), 153-160 (2013).
37. Feigelson HS, Bischoff K, Ardini MA et al. Feasibility of self-collection of fecal specimens by randomly sampled women for healthrelated studies of the gut microbiome. BMC Res. Notes 7(1), 204 (2014).
38. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107(33), 14691-14696 (2010).
39. Dominianni C, Wu J, Hayes RB, Ahn J. Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol. 14(1), 103 (2014).
40. Wesolowska-Andersen A, Bahl MI, Carvalho V et al. Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis. Microbiome 2, 19 (2014).
41. Kleiner M, Hooper LV, Duerkop BA. Evaluation of methods to purify virus-like particles for metagenomic sequencing of intestinal viromes. BMC Genomics 16(1), 7 (2015).
42. Minot S, Sinha R, Chen J et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21(10), 1616-1625 (2011).
43. Perez-Brocal V, Garcia-Lopez R, Vazquez-Castellanos JF et al. Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach. Clin. Transl. Gastroenterol. 4, e36 (2013).
44. Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 36(5), 808-812 (2004).
45. Salonen A, Nikkila J, Jalanka-Tuovinen J et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J. Microbiol. Methods 81(2), 127-134 (2010).
46. Godon JJ, Zumstein E, Dabert P, Habouzit F, Moletta R. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl. Environ. Microbiol. 63(7), 2802-2813 (1997).
47. Mirsepasi H, Persson S, Struve C, Andersen LO, Petersen AM, Krogfelt KA. Microbial diversity in fecal samples depends on DNA extraction method: Easymag DNA extraction compared with qiaamp DNA stool mini kit extraction. BMC Res. Notes 7(1), 50 (2014).
48. Kennedy NA, Walker AW, Berry SH et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16s rRNA gene sequencing. PLoS ONE 9(2), e88982 (2014).
49. Claassen S, Du Toit E, Kaba M, Moodley C, Zar HJ, Nicol MP. A comparison of the efficiency of five different commercial DNA extraction kits for extraction of DNA from faecal samples. J. Microbiol. Methods 94(2), 103-110 (2013).
50. Van Zanten E, Wisselink GJ, De Boer W, Stoll S, Alvarez R, Kooistra-Smid AM. Comparison of the qiasymphony automated nucleic acid extraction and PCR setup platforms with nuclisens Easymag and Corbett CAS-1200 liquid handling station for the detection of enteric pathogens in fecal samples. J. Microbiol. Methods 84(2), 335-340 (2011).
51. Wagner Mackenzie B, Waite DW, Taylor MW. Evaluating variation in human gut microbiota profiles due to DNA extraction method and inter-subject differences. Front. Microbiol. 6, 130 (2015).
52. Woese CR. Bacterial evolution. Microbiol. Rev. 51(2), 221-271 (1987).
53. Cole JR, Wang Q, Fish JA et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. . 42(Database issue), D633-D642 (2014). http://rdp. cme. msu. edu/
54. University of Michigan. Center for Microbial Systems. rrnDB. http://rrndb. umms. med. umich. edu/
55. Lee ZM, Bussema C 3rd, Schmidt TM. Rrndb: documenting the number of rRNA and tRNA genes in bacteria and archaea. Nucleic Acids Res. 37(Database issue), D489-D493 (2009).
56. Sun DL, Jiang X, Wu QL, Zhou NY. Intragenomic heterogeneity of 16s rRNA genes causes overestimation of prokaryotic diversity. Appl. Environ. Microbiol. 79(19), 5962-5969 (2013).
57. Kembel SW, Wu M, Eisen JA, Green JL. Incorporating 16s gene copy number information improves estimates of microbial diversity and abundance. PLoS Comput. Biol. 8(10), e1002743 (2012).
58. Vetrovsky T, Baldrian P. The variability of the 16s rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS ONE 8(2), e57923 (2013).
59. Bodilis J, Nsigue-Meilo S, Besaury L, Quillet L. Variable copy number, intra-genomic heterogeneities and lateral transfers of the 16s rRNA gene in pseudomonas. PLoS ONE 7(4), e35647 (2012).
60. Angly FE, Dennis PG, Skarshewski A, Vanwonterghem I, Hugenholtz P, Tyson GW. Copyrighter: a rapid tool for improving the accuracy of microbial community profiles through lineage-specific gene copy number correction. Microbiome 2(1), 11 (2014).
61. Group JCHMPDGW. Evaluation of 16s rDNA-based community profiling for human microbiome research. PLoS ONE 7(6), e39315 (2012).
62. Huse SM, Ye Y, Zhou Y, Fodor AA. A core human microbiome as viewed through 16s rRNA sequence clusters. PLoS ONE 7(6), e34242 (2012).
63. Mosher JJ, Bowman B, Bernberg EL et al. Improved performance of the PacBio SMRT technology for 16s rDNA sequencing. J. Microbiol. Methods 104, 59-60 (2014).
64. Rogall T, Wolters J, Flohr T, Bottger EC. Towards a phylogeny and definition of species at the molecular level within the genus mycobacterium. Int. J. Syst. Bacteriol. 40(4), 323-330 (1990).
65. Farris MH, Olson JB. Detection of actinobacteria cultivated from environmental samples reveals bias in universal primers. Lett. Appl. Microbiol. 45(4), 376-381 (2007).
66. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16s rRNA-based studies. PLoS ONE 6(12), e27310 (2011).
67. Pinto AJ, Raskin L. PCR biases distort bacterial and archaeal community structure in pyrosequencing datasets. PLoS ONE 7(8), e43093 (2012).
68. Esposito A, Kirschberg M. How many 16s-based studies should be included in a metagenomic conference It may be a matter of etymology. FEMS Microbiol. Lett. 351(2), 145-146 (2014).
69. Hill JE, Penny SL, Crowell KG, Goh SH, Hemmingsen SM. CPNDB: a chaperonin sequence database. Genome Res. 14(8), 1669-1675 (2004).
70. Hill JE, Town JR, Hemmingsen SM. Improved template representation in Cpn60 polymerase chain reaction (PCR) product libraries generated from complex templates by application of a specific mixture of PCR primers. Environ. Microbiol. 8(4), 741-746 (2006).
71. Hill JE, Fernando WM, Zello GA, Tyler RT, Dahl WJ, Van Kessel AG. Improvement of the representation of Bifidobacteria in fecal microbiota metagenomic libraries by application of the Cpn60 universal primer cocktail. Appl. Environ. Microbiol. 76(13), 4550-4552 (2010).
72. Vos M, Quince C, Pijl AS, De Hollander M, Kowalchuk GA. A comparison of rpob and 16s rRNA as markers in pyrosequencing studies of bacterial diversity. PLoS ONE 7(2), e30600 (2012).
73. Gill SR, Pop M, Deboy RT et al. Metagenomic analysis of the human distal gut microbiome. Science 312(5778), 1355-1359 (2006).
74. Shakya M, Quince C, Campbell JH, Yang ZK, Schadt CW, Podar M. Comparative metagenomic and rRNA microbial diversity characterization using archaeal and bacterial synthetic communities. Environ. Microbiol. 15(6), 1882-1899 (2013).
75. Manichanh C, Chapple CE, Frangeul L, Gloux K, Guigo R, Dore J. A comparison of random sequence reads versus 16s rDNA sequences for estimating the biodiversity of a metagenomic library. Nucleic Acids Res. 36(16), 5180-5188 (2008).
76. Poretsky R, Rodriguez RL, Luo C, Tsementzi D, Konstantinidis KT. Strengths and limitations of 16s rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS ONE 9(4), e93827 (2014).
77. Qin J, Li Y, Cai Z et al. A metagenome-wide association study of gut microbiota in Type 2 diabetes. Nature 490(7418), 55-60 (2012).
78. Nielsen HB, Almeida M, Juncker AS et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32(8), 822-828 (2014).
79. Di Rienzi SC, Sharon I, Wrighton KC et al. The human gut and groundwater harbor non-photosynthetic bacteria belonging to a new candidate phylum sibling to cyanobacteria. eLife 2, e01102 (2013).
80. Lin HV, Frassetto A, Kowalik EJ Jr. et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7(4), e35240 (2012).
81. Haiser HJ, Turnbaugh PJ. Developing a metagenomic view of xenobiotic metabolism. Pharmacol. Res. 69(1), 21-31 (2013).
82. Schloissnig S, Arumugam M, Sunagawa S et al. Genomic variation landscape of the human gut microbiome. Nature 493(7430), 45-50 (2013).
83. Hu Y, Yang X, Qin J et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 4, 2151 (2013).
84. Norman JM, Handley SA, Virgin HW. Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology 146(6), 1459-1469 (2014).
85. Duerkop BA, Hooper LV. Resident viruses and their interactions with the immune system. Nat. Immunol. 14(7), 654-659 (2013).
86. Iliev ID, Funari VA, Taylor KD et al. Interactions between commensal fungi and the c-type lectin receptor dectin-1 influence colitis. Science 336(6086), 1314-1317 (2012).
87. Casellas F, Antolin M, Varela E et al. Fecal excretion of human deoxyribonucleic acid as an index of inflammatory activity in ulcerative colitis. Clin. Gastroenterol. Hepatol. 2(8), 683-689 (2004).
88. Van Dijk EL, Jaszczyszyn Y, Thermes C. Library preparation methods for nextgeneration sequencing: tone down the bias. Exp. Cell Res. 322(1), 12-20 (2014).
89. Westermann AJ, Gorski SA, Vogel J. Dual RNA-seq of pathogen and host. Nat. Rev. Microbiol. 10(9), 618-630 (2012).
90. Feehery GR, Yigit E, Oyola SO et al. A method for selectively enriching microbial DNA from contaminating vertebrate host DNA. PLoS ONE 8(10), e76096 (2013).
91. Biesbroek G, Sanders EA, Roeselers G et al. Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS ONE 7(3), e32942 (2012).
92. Luo C, Rodriguez RL, Konstantinidis KT. A user's guide to quantitative and comparative analysis of metagenomic datasets. Methods Enzymol. 531, 525-547 (2013).
93. Kim M, Lee K-H, Yoon S-W, Kim B-S, Chun J, Yi H. Analytical tools and databases for metagenomics in the next-generation sequencing era. Genomics Informatics 11(3), 102-113 (2013).
94. Hayden EC. Technology: the 1,000 genome. Nature 507(7492), 294-295 (2014).
95. Ashton PM, Nair S, Dallman T et al. MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island. Nat. Biotechnol. 33(3), 296-300 (2014).
96. Quail MA, Smith M, Coupland P et al. A tale of three next generation sequencing platforms: comparison of ion torrent, pacific biosciences and illumina miseq sequencers. BMC Genomics 13, 341 (2012).
97. Collins FS, Hamburg MA. First fda authorization for next-generation sequencer. N. Engl. J. Med. 369(25), 2369-2371 (2013).
98. Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol. Cell 58(4), 586-597 (2015).
99. The Molecular Ecologist. 2014 NGS Field Guide: Overview. www. molecularecologist. com
100. Glenn TC. Field guide to next-generation DNA sequencers. Mol. Ecol. Resour. 11(5), 759-769 (2011).
101. Jeon YS, Park SC, Lim J, Chun J, Kim BS. Improved pipeline for reducing erroneous identification by 16s rRNA sequences using the illumina miseq platform. J. Microbiol. 53(1), 60-69 (2015).
102. Haas BJ, Gevers D, Earl AM et al. Chimeric 16s rRNA sequence formation and detection in sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21(3), 494-504 (2011).
103. BEI Resources. www. beiresources. org
104. Salipante SJ, Kawashima T, Rosenthal C et al. Performance comparison of illumina and ion torrent next-generation sequencing platforms for 16s rRNA-based bacterial community profiling. Appl. Environ. Microbiol. 80(24), 7583-7591 (2014).
105. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the miseq illumina sequencing platform. Appl. Environ. Microbiol. 79(17), 5112-5120 (2013).
106. Hang J, Desai V, Zavaljevski N et al. 16s rRNA gene pyrosequencing of reference and clinical samples and investigation of the temperature stability of microbiome profiles. Microbiome 2, 31 (2014).
107. Mende DR, Waller AS, Sunagawa S et al. Assessment of metagenomic assembly using simulated next generation sequencing data. PLoS ONE 7(2), e31386 (2012).
108. Del Fabbro C, Scalabrin S, Morgante M, Giorgi FM. An extensive evaluation of read trimming effects on illumina NGS data analysis. PLoS ONE 8(12), e85024 (2013).
109. Zhou Q, Su X, Ning K. Assessment of quality control approaches for metagenomic data analysis. Sci Rep 4, 6957 (2014).
110. Plaza Onate F, Batto JM, Juste C et al. Quality control of microbiota metagenomics by k-mer analysis. BMC Genomics 16(1), 1406 (2015).
111. US FDA. Optimizing FDA's regulatory oversight of next generation sequencing diagnostic tests-preliminary discussion paper. December 2014.
112. IHM. http://www. microbiome-standards. org/
113. The Microbiome Quality Control project. http://www. mbqc. org/